Rapid increase in serum levels of matrix metalloproteinase-9 (MMP-9) postoperatively is associated with a decrease in the amount of intracellular MMP-9

Belizon, Avraham; Kirman, Irena; Karten, Moshe; Jain, Suvinit; Whelan, Richard L.
December 2005
Surgical Innovation;Dec2005, Vol. 12 Issue 4, p333
Academic Journal
journal article
We have previously demonstrated a significant decrease in the serum concentration of intact insulin-like growth factor-binding protein (IGFBP-3) after laparotomy. IGFBP-3, a major IGF binding protein, inhibits the growth of tumor cells via several mechanisms. Our goal was to determine, in a murine model, whether matrix metalloproteinase-9 (MMP-9), a known protease of IGFBP-3, is responsible for the postoperative decrease in serum IGFBP-3 levels. Six IGFBP-3 transgenic mice on a CD-1 background were used in this study. These mice over-express human IGFBP-3. Sham laparotomy, in the form of a midline abdominal incision, was the test procedure. General anesthesia was established using ketamine and xylazine immediately before a 30-minute sham laparotomy and before preoperative blood sampling, done via retro-orbital venipuncture, 48 hours before surgery. The animals were sacrificed and blood was drawn 24 hours postoperatively. Plasma MMP-9 activity was measured using zymography at each time point (48 hours before and 24 hours after operation). MMP-9 activity was also measured in mononuclear cell lysates at both time points. Zymography analysis demonstrated significantly higher plasma levels of MMP-9 postoperatively compared with preoperative levels (81 RU vs 40 RU; P < .05). In contrast, mononuclear cell levels of MMP-9 were significantly higher preoperatively compared with postoperative levels (37.5 RU vs. 0.75 RU, P < .05). Plasma levels of MMP-9, a known protease of IGFBP-3, are significantly elevated postoperatively. In addition, mononuclear cells that store MMP-9 are depleted of it postoperatively. This suggests that rapid MMP-9 release by mononuclear cells leads to an increase in serum levels of this protease postoperatively. Further studies will elucidate mechanisms of MMP-9-related IGFBP-3 depletion.


Related Articles

  • IGFBP-1 forms associated with placental cell membranes. Masnikosa, Romana; Živković, Bogovid; Nedić, Olgica // Journal of the Serbian Chemical Society;Jul2009, Vol. 74 Issue 7, p707 

    Fetal growth in utero depends on the proper development and function of the placenta. Insulin-like growth factors (IGFs) are critically involved in placental development. During pregnancy, an IGF-binding protein, IGFBP-1, which is produced by maternal decidua, plays an important role in the...

  • Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9. Belizon, A.; Kirman, I.; Balik, E.; Karten, M.; Jain, S.; Whelan, R.; Whelan, R L // Surgical Endoscopy;Apr2007, Vol. 21 Issue 4, p653 

    Background: The authors previously demonstrated a significant decrease in plasma levels of intact insulin-like growth factor binding protein-3 (IGFBP-3) after major open but not after laparoscopic-assisted surgery in humans. They postulated that this decrease may have an effect on...

  • Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis. Wilczak, N.; Ramsaransing, G. S. M.; Mostert, J.; Chesik, D.; de Keyser, J. // Multiple Sclerosis (13524585);Feb2005, Vol. 11 Issue 1, p13 

    Using radioimmunoassay we measured serum levels of insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-3 in patients with relapsing multiple sclerosis (MS) and a benign course (Expanded Disability Status Scale (EDSS) = 3 despite > 10 years disease duration), relapsing MS with...

  • Insulin-Like Growth Factors | Binding.  // Current Medical Literature: GH & Growth Factors;2003, Vol. 18 Issue 3, p78 

    Discusses abstracts on insulin-like growth factors and binding proteins. "The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study," by M.S. Boyne et al; "A novel insulin-like growth factor...

  • Insulin-like Growth Factor (IGF) Binding Protein Proteases: Key Regulators of IGF Action. Conover, Cheryl A. // Current Medical Literature: GH & Growth Factors;2004, Vol. 19 Issue 3, p57 

    Discusses the function of insulin-like growth factor binding protein proteases (IGFBP) proteolysis in normal physiology. Characterization of IGFBP protease; Details on the interaction of insulin-like growth factor with receptors; Implications of IGFBP in human physiology and pathophysiology.

  • Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Gram, I. T.; Norat, T.; Rinaldi, S.; Dossus, L.; Lukanova, A.; Téhard, B.; Clavel-Chapelon, F.; van Gils, C. H.; van Noord, P. A. H.; Peeters, P. H. M.; Bueno-de-Mesquita, H. B.; Nagel, G.; Linseisen, J.; Lahmann, P. H.; Boeing, H.; Palli, D.; Sacerdote, C.; Panico, S.; Tumino, R.; Sieri, S. // International Journal of Obesity;Nov2006, Vol. 30 Issue 11, p1623 

    Objective: To examine the relationship between body mass index (BMI) and waist-hip ratio (WHR) with serum levels of insulin-like growth factor-I (IGF-I), and its binding protein (IGFBP)-3.Design: Cross-sectional study on 2139 women participating in a case-control study...

  • Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy. Hassfeld, Sabine; Eichhorn, Christina; Stehr, Katla; Naegele, Herbert; Geier, Christian; Steeg, Martin; Ranke, Michael B.; Oezcelik, Cemil; Osterziel, Karl Josef // Heart;Mar2007, Vol. 93 Issue 3, p359 

    The article discusses a study which examined the role of insulin-like growth factor (IGF)-binding proteins (BP) 2 and 3 as predictors of a poor prognosis in patients with idiopathic dilated cardiomyopathy. The study demonstrated that low IGF1 and IGFBP3 levels and high IGFBP2 levels are...

  • Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia. Sifakis, S; Akolekar, R; Kappou, D; Mantas, N; Nicolaides, K H // Journal of Human Hypertension;Apr2012, Vol. 26 Issue 4, p253 

    The objective of this study was to determine if the maternal serum concentration of insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 week's gestation is altered in pregnancies that subsequently develop preeclampsia (PE). Maternal serum concentration of IGFBP-3,...

  • Somatomedin-1 binding protein-3.  // BioDrugs;2003, Vol. 17 Issue 5, p375 

    Somatomedin-1 binding protein-3 [insulin-like growth factor-1 binding protein-3, SomatoKine®] is a recombinant complex of insulin-like growth factor-1 (rhIGF-1) and binding protein-3 (IGFBP-3), which is the major circulating somatomedin (insulin-like growth factor) binding protein; binding...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics